Among the mediators, a high concentration of TGF-β2 in AH is a key factor in glaucoma progression, along with glaucomatous pathological changes in the outflow pathway such as fibrosis and deposition of ECM protein37,38. This evidence concerns the gene TGFB2 and glaucoma.